Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients

Clinical trial NCT02856178 · WITHDRAWN

Trial details

NCT number: NCT02856178
Sponsor: F2G Ltd
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pulmonary Aspergillosis - Invasive Acute Myeloid Leukemia

Start date: 2017-04-20
Primary completion: 2017-04-20
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.